Skip to main content
. 2020 Oct 27;61(6):539–554. doi: 10.4111/icu.20200317

Table 1. Widely accepted classifications of BC based on molecular phenotypes.

UNC MDA Lund TCGA Broad
Basal Basal UroA Cluster I Basal
Luminal Luminal UroB Cluster II Luminal
Claudin-low P53-like GU Cluster III Luminal immune
SCCL Cluster IV Immune undifferentiated
Infiltrated

BC, bladder cancer; UNC, the University of North Carolina; MDA, MD Anderson Cancer Center; Lund, Lund University; TCGA, The Cancer Genome Atlas; Broad, Broad Institute of Massachusetts Institute of Technology and Harvard University; UroA, urobasal A; UroB, urobasal B; GU, genomically unstable; SCCL, squamous cell carcinoma like.